Proper cryoprotectants improving properties ofL. plantarum LIP-1 microcapsules
Tian Wenjing,Wang Junguo,Song Jiaojiao,Yue Linfang,Wang Yali,Bao Qiuhua,Zhang Heping,Bilige Menghe
DOI: https://doi.org/10.11975/j.issn.1002-6819.2015.21.038
2015-01-01
Abstract:As all know, probiotics have many physiological functions, but the actual levels detected in probiotic products are often much lower due to adverse conditions during product storage, transportation, marketing and consumption. Many studies have shown that, microencapsulation techniques can provide protection against adverse conditions for probiotics. In order to enhance the storage stability of microcapsule, freeze drying is commonly used, but freeze-drying technique exposes the bacterial cells to additional stressful processing steps and the loss in viability of cells was observed. To prevent these adverse effects, cryoprotectants are commonly added to samples before freeze drying. In this study, we investigated the optimal ratio of cryoprotectants and the effect of cryoprotectants on the properties ofL. plantarum LIP-1 microcapsules. Single factor and orthogonal experimental design were used to study the influence of adding different types of cryoprotectants on microencapsulation efficiency (ME) and survival rate of LIP-1 during freeze-drying process. Based on those data, the effect of optimal cryoprotectants on the properties ofL. plantarum LIP-1 microcapsules was evaluated, such as surface morphology and microstructure by scanning electron microscopy (SEM), simulated gastricfluid (SGF) resistance, release characteristic in simulated intestinalfluid (SIF) and viability during four-week storage at different temperatures (4, 20 and 37°C). The results showed that the best cryoprotectant formulations were glycerol of 2%, maltose of 1%, L-cysteine of 2% and lactose of 2%, andbased on this formulation, the ME was 67.60% and the survival rate was 83.80%, which increased the number of living bactera after freeze drying significantly (P<0.05) compared with the blank (microcapsules without cryoprotectants, the ME and the survival rate were 70.5% and 56.41%, respectively). The microcapsules with optimal cryoprotectants indicated a compact microcapsule structure and regular shape, and a finer and more dispersed substructure than the blank. The microcapsules with optimal cryoprotectants had significantly faster release properties in SIF than the blank, for the microcapsules with optimal cryoprotectants werecompletely released within 60 min, while the blank took 90 min to be fully released, which was maybe due to the difference in size and distribution status of those microcapsules. The size of microcapsules with optimal cryoprotectants was smaller and the distribution was better than the blank, resulting in a larger specific surface area for enzyme activity, and the increase of the speed of disintegration. The microcapsules with optimal cryoprotectants had a better SGF resistance than the blank. And in our study, free cells of LIP-1 were sensitive to low pH value, the viability began to decrease significantly (P<0.05) within 30 min, and they lost about 90% when exposed to acidic conditions for 120 min; the viability of microcapsules in blank began to decrease significantly (P<0.05) after 90 min, and lost about 44% when exposed to acidic conditions for 150 min; while the viability of microcapsules with optimal cryoprotectants began to decrease significantly (P<0.05) after 120 min, and they lost about 30% when exposed to acidic conditions for 150 min. So the microencapsulation provided a significant protection forL. plantarum under acidic conditions, and cryoprotectants could enhance the SGF resistance of LIP-1 significantly. Maybe because the surface of microcapsules with optimal cryoprotectants was denser, and had less aperture, it was likely to be more resistant to the penetration of SGF. The viability of microcapsules was significantly (P<0.05) higher than free cells during four- week storage at different temperatures (4, 20 and 37°C), while the viability of microcapsules with optimal cryoprotectants was significantly (P<0.05) higher than the blank. So the microencapsulation provided a significant protection forL. plantarumduring storage at different temperature, and the microcapsules with optimal cryoprotectants could significantly (P<0.05) increase the viability of LIP-1 during storage at different temperature, for the dense membrane formed around the microcapsules may provide effective protection by separating LIP-1 from harmful factors, such as air, moisture, light. In addition, the oxidative stability of L-cysteine was in favor of the storage of microcapsules. Therefore, the results indicate that the adding of optimal cryoprotectants can improve the properties ofL. plantarum LIP-1 microcapsules significantly, and also provide a theoretical basis and technical guidance for improving the properties of probiotic microcapsules during the commercial production.